Anti-PCSK9 Neutralizing Antibody (V3S-0622-YC5179) (CAT#: V3S-0622-YC5179)

Send Inquiry
  • fig1
    Figure 1 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in ELISA
  • fig1
    Figure 2 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in DB

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with PCSK9. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application DB; FC; IP; ELISA; Neut; FuncS; IF; IHC
Application Notes The antibody is recommended for detection of PCSK9 by FC, IP, ELISA, Neut, FuncS, IF, IHC assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target PCSK9
Alternative Name FH3; PC9; FHCL3; NARC1; LDLCQ1; NARC-1; HCHOLA3
Gene ID 255738
UniProt Q8NBP7
Related pathway Secretory pathway
Research Area Signal Pathway; Cardiovascular

Tested Data

ELISA

Figure 1 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in ELISA

ELISA analysis of V3S-0622-YC5179 was performed by coating with Human PCSK9 Protein (His Tag). Then blocked with BSA and incubated with V3S-0622-YC5179. The HRP-conjugated goat anti-human IgG as a secondary antibody (1: 4000). Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 1 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in ELISA

DB

Figure 2 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in DB

Dot Blot analysis of V3S-0622-YC5179 was performed by coating with Human PCSK9 Protein (His Tag).

V3S-0622-YC5179 incubation concentration: 2 μg/mL.
HRP-conjugated goat anti-human IgG as a secondary antibody (1: 3000)

Figure 2 Anti-PCSK9 Monoclonal Antibody (V3S-0622-YC5179) in DB

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry